180
Views
0
CrossRef citations to date
0
Altmetric
Review

Autophagy-Regulating N-Heterocycles Derivatives as Potential Anticancer Agents

ORCID Icon, , , , , , , , , , , , & show all
Pages 223-242 | Received 24 Oct 2019, Accepted 26 Nov 2019, Published online: 11 Dec 2019
 

Abstract

As a double-edged sword, autophagy in cancer cells could either suppress or promote tumorigenesis. Nowadays, more and more natural compounds with autophagy-regulating activities exhibit therapeutic effects against various cancers. N-Heterocycle derivatives plays an important role for discovery new drugs. In this review, we summarize and classify 116 N-heterocycle derivatives with autophagy-regulating activities in the past decade into 12 classes according to structure characteristics. The structural features, bioactivities, mechanism and problems faced in this field are discussed and reported for the first time. Some of these even exhibited outstanding in vivo antitumor activities, including bisaminoquinoline (3), pancratistatin (8), 10-hydroxyevodiamine (18), lycorine (28), piperine (31) and iridium (III) complex (57), which are potential drug candidates for antitumor therapy.

Author contributions

As first author and corresponding author, XX Liang organized and wrote the whole manuscript. Co-first author, L Zhang gave the idea and careful revision of the manuscript. FL Li and SX Luan drew the related figures and gave suggestions to improve the manuscript. CL He, LZ Yin, ZQ Yin, YF Zou and GZ Yue edited and corrected the final version of the manuscript. LX Li, X Song, C Lv, W Zhang and B Jing searched the related references.

Financial & competing interests disclosure

Financial support from NSFC (81703387, 31972743) and Drug Innovation Group of China Agricultural Research System (CARS-SVDIP) are greatly appreciated. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.